These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
604 related articles for article (PubMed ID: 10371169)
61. Prospective study of CD8+ lymphocyte activation in relation to viral load in HIV-infected patients with > or = 400 CD4+ lymphocytes per microliter. Bouscarat F; Levacher M; Dazza MC; Chau F; Desforges B; Muffat-Joly M; Matheron S; Girard PM; Sinet M AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1419-25. PubMed ID: 10555104 [TBL] [Abstract][Full Text] [Related]
62. Frequency of cytokine-producing T cells in HIV-infected patients treated with stavudine, didanosine, and ritonavir. Levacher M; Bouscarat F; Landman R; Chau F; Damond F; Gaudebout C; Mathez D; Leibowitch J; Saimot AG; Sinet M AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1869-75. PubMed ID: 11118072 [TBL] [Abstract][Full Text] [Related]
63. Expression of CD28 and CD38 by CD8+ T lymphocytes in HIV-1 infection correlates with markers of disease severity and changes towards normalization under treatment. The Swiss HIV Cohort Study. Bürgisser P; Hammann C; Kaufmann D; Battegay M; Rutschmann OT Clin Exp Immunol; 1999 Mar; 115(3):458-63. PubMed ID: 10193418 [TBL] [Abstract][Full Text] [Related]
64. Interferon-alpha differentially rescues CD4 and CD8 T cells from apoptosis in HIV infection. Rodriguez B; Lederman MM; Jiang W; Bazdar DA; Gàrate K; Harding CV; Sieg SF AIDS; 2006 Jun; 20(10):1379-89. PubMed ID: 16791012 [TBL] [Abstract][Full Text] [Related]
65. Effects of primary HIV-1 infection on subsets of CD4+ and CD8+ T lymphocytes. Zaunders J; Carr A; McNally L; Penny R; Cooper DA AIDS; 1995 Jun; 9(6):561-6. PubMed ID: 7662193 [TBL] [Abstract][Full Text] [Related]
66. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells. Ramzaoui S; Jouen-Beades F; Gilbert D; Borsa-Lebas F; Michel Y; Humbert G; Tron F Clin Immunol Immunopathol; 1995 Oct; 77(1):33-41. PubMed ID: 7554481 [TBL] [Abstract][Full Text] [Related]
67. Activated naive and memory CD4+ and CD8+ subsets in different stages of HIV infection. Ginaldi L; De Martinis M; D'Ostilio A; Di Gennaro A; Marini L; Profeta V; Quaglino D Pathobiology; 1997; 65(2):91-9. PubMed ID: 9253033 [TBL] [Abstract][Full Text] [Related]
68. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals. Kolber MA AIDS; 2008 Oct; 22(15):1937-41. PubMed ID: 18784457 [TBL] [Abstract][Full Text] [Related]
69. Increased levels of activated subsets of CD4 T cells add to the prognostic value of low CD4 T cell counts in a cohort of HIV-infected drug users. Carbone J; Gil J; Benito JM; Navarro J; Muñóz-Fernández A; Bartolomé J; Zabay JM; López F; Fernández-Cruz E AIDS; 2000 Dec; 14(18):2823-9. PubMed ID: 11153663 [TBL] [Abstract][Full Text] [Related]
70. Elevated CD69 expression on naive peripheral blood T-cells in hyperthyroid Graves' disease and autoimmune thyroiditis: discordant effect of methimazole on HLA-DR and CD69. Gessl A; Waldhäusl W Clin Immunol Immunopathol; 1998 May; 87(2):168-75. PubMed ID: 9614932 [TBL] [Abstract][Full Text] [Related]
71. Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease. Rodrigues DS; Medeiros EA; Weckx LY; Bonnez W; Salomão R; Kallas EG Clin Exp Immunol; 2002 Apr; 128(1):149-54. PubMed ID: 11982602 [TBL] [Abstract][Full Text] [Related]
72. Segregation of R5 and X4 HIV-1 variants to memory T cell subsets differentially expressing CD62L in ex vivo infected human lymphoid tissue. Gondois-Rey F; Grivel JC; Biancotto A; Pion M; Vigne R; Margolis LB; Hirsch I AIDS; 2002 Jun; 16(9):1245-9. PubMed ID: 12045489 [TBL] [Abstract][Full Text] [Related]
73. The chemokine receptor CX3CR1 controls homing and anti-viral potencies of CD8 effector-memory T lymphocytes in HIV-infected patients. Combadière B; Faure S; Autran B; Debré P; Combadière C AIDS; 2003 Jun; 17(9):1279-90. PubMed ID: 12799549 [TBL] [Abstract][Full Text] [Related]
74. Phenotypic characterization of regulatory T cells from antiretroviral-naive HIV-1-infected people. Ambada GN; Ntsama CE; Nji NN; Ngu LN; Sake CN; Lissom A; Tchouangeu FT; Tchadji J; Sosso M; Etoa FX; Nchinda GW Immunology; 2017 Aug; 151(4):405-416. PubMed ID: 28375551 [TBL] [Abstract][Full Text] [Related]
75. Impact of suppression of viral replication by highly active antiretroviral therapy on immune function and phenotype in chronic HIV-1 infection. Lange CG; Lederman MM; Madero JS; Medvik K; Asaad R; Pacheko C; Carranza C; Valdez H J Acquir Immune Defic Syndr; 2002 May; 30(1):33-40. PubMed ID: 12048361 [TBL] [Abstract][Full Text] [Related]
76. Immunologic effects of combined protease inhibitor and reverse transcriptase inhibitor therapy in previously treated chronic HIV-1 infection. Giorgi JV; Majchrowicz MA; Johnson TD; Hultin P; Matud J; Detels R AIDS; 1998 Oct; 12(14):1833-44. PubMed ID: 9792384 [TBL] [Abstract][Full Text] [Related]
77. Distinct alterations in the distribution of CD45RO+ T-cell subsets in HIV-2 compared with HIV-1 infection. Jaleco AC; Covas MJ; Pinto LA; Victorino RM AIDS; 1994 Dec; 8(12):1663-8. PubMed ID: 7888114 [TBL] [Abstract][Full Text] [Related]
78. Correlation of T-lymphocyte subpopulations with immunological markers in HIV-1-infected Indian patients. Kaushik S; Vajpayee M; Sreenivas V; Seth P Clin Immunol; 2006 Jun; 119(3):330-8. PubMed ID: 16476571 [TBL] [Abstract][Full Text] [Related]
79. Expansion of CD8+CD57+ T cells after allogeneic BMT is related with a low incidence of relapse and with cytomegalovirus infection. Dolstra H; Preijers F; Van de Wiel-van Kemenade E; Schattenberg A; Galama J; de Witte T Br J Haematol; 1995 Jun; 90(2):300-7. PubMed ID: 7540855 [TBL] [Abstract][Full Text] [Related]
80. CD4(+) T-cell immunodeficiency is more dependent on immune activation than viral load in HIV-infected children on highly active antiretroviral therapy. Resino S; Seoane E; Gutiérrez MD; León JA; Muñoz-Fernández MA J Acquir Immune Defic Syndr; 2006 Jul; 42(3):269-76. PubMed ID: 16810122 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]